BUY Gland Pharma Limited — Ashish Bahety, Profitmart Securities
byAshish Bahety, Profitmart SecuritiesHorizon: NA (inferred Swing (≤2wk))28 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 advisors have active short-term BUY calls on this stock
Advisor consensus · adjacent horizon·13 Oct · 2w ago
MACD below its signal line — bearish momentum
Technicals · macd·28 Oct · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Gland Pharma
- BUY — Vishnu Kant Upadhyay, Master Capital Services13 Oct 2026 · ~3 months · target ₹3,400 · Active
- BUY — Kunal Parar, Choice Broking8 Oct 2026 · Same day · target ₹3,235 · Expired
- BUY — Prakash Gaba7 Oct 2026 · ~2 weeks · target ₹3,200 · SL hit
- BUY — Nomura India Research7 Oct 2026 · ~1 year · target ₹3,750 · Active
- BUY — Raja Venkatraman7 Oct 2026 · ~3 months · target ₹3,325 · SL hit
More from Ashish Bahety, Profitmart Securities
- BUY Indus Towers28 Oct 2026 · Same day · target ₹395 · SL hit
- BUY Samvardhana Motherson International28 Oct 2026 · ~2 weeks · target ₹162 · Active
- BUY Divi's Laboratories27 Oct 2026 · ~2 weeks · target ₹9,800 · Active
- BUY Canara Bank27 Oct 2026 · Same day · target ₹120 · Expired
- BUY Kotak Mahindra Bank27 Oct 2026 · Same day · target ₹450 · Expired

